🔎 Trials Near Me

ホーム › 膀胱癌 › カンザス州

カンザス州における膀胱癌の臨床試験

カンザス州内の拠点で、膀胱癌に関する17件の研究が参加者を募集しています。

カンザス州内の都市

公式研究テキスト(英語)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Central Care Cancer Center - Garden City, Garden City
  • Central Care Cancer Center - Great Bend, Great Bend
  • Veteran Administration Eastern Kansas Healthcare, Leavenworth
  • 他4件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

  • University of Kansas Cancer Center, Kansas City
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06770582

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • HaysMed, Hays
  • Lawrence Memorial Hospital, Lawrence
  • The University of Kansas Cancer Center - Olathe, Olathe
  • 他4件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

  • The University of Kansas - Clinical Research Center, Fairway
  • The University of Kansas Hospital Cambridge North Tower A, Kansas City
  • The University of Kansas Hospital, Kansas City
  • 他3件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07206225

DESTINY-PANTUMOUR04

  • Research Site, Topeka
被験者募集中観察研究
18歳〜130歳 · 全性別 · 2026/09/25更新 · NCT07124000

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

  • Wichita Urology Group, Wichita
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06567743

Measuring Surgical Recovery After Radical Cystectomy

  • University of Kansas Medical Center, Lawrence
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/19更新 · NCT03193970

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

  • Central Care Cancer Center - Garden City, Garden City
  • University of Kansas Cancer Center, Kansas City
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07097142

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • The University of Kansas Cancer Center, Kansas City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT05592626

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

  • University of Kansas Medical Center, Kansas City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/07更新 · NCT04752722

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • The University of Kansas Cancer Center, Investigational Drug Services, Fairway
  • The University of Kansas Clinical Research Center, Fairway
  • The University of Kansas Hospital, Kansas City
  • 他6件
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/06更新 · NCT04389632

Integrated Cancer Repository for Cancer Research

  • Saint Luke's Cancer Instititute - South, Overland Park
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699

Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS)

  • University of Kansas Medical Center, Kansas City
  • University of Kansas Medical Center, Kansas City
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/20更新 · NCT06721260

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

  • University of Kansas Medical Center, Kansas City
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/10更新 · NCT03413982

Blue Light Cystoscopy With Cysview® Registry

  • University of Kansas Medical Center, Kansas City
被験者募集中観察研究
18歳以上 · 全性別 · 2025/12/18更新 · NCT02660645

Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer

  • The University of Kansas Cancer Center, Kansas City
被験者募集中第2相
18歳以上 · 全性別 · 2025/02/20更新 · NCT06493370

LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors

  • University of Kansas Medical Center, Kansas City
被験者募集中観察研究
18歳以上 · 全性別 · 2024/10/16更新 · NCT04979156

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。